Azenta AZTA Multiomics — Depreciation Expense

Similar metrics at other companies

DHRBiotechnology — Depreciation

$40M+17.6%

ALife Sciences and Diagnostics Markets — Depreciation

$26M+8.3%

PTCTLife Science — Depreciation

$3.81M+10.1%

PENGIntegrated Memory — Depreciation expense

$892K-5.8%

GATXOther — Depreciation expense

$4.1M+10.8%

AVT

AVTRBioscience & Medtech Products — D&A

$49.2M+12.3%

Questions, answered.

What is Azenta's multiomics — depreciation expense?

Azenta (AZTA) reported multiomics — depreciation expense of $3.96M in Q1 2026.

How has Azenta's multiomics — depreciation expense changed year-over-year?

Azenta's multiomics — depreciation expense increased by 8.4% year-over-year, from $3.65M to $3.96M.

What does multiomics — depreciation expense mean?

The systematic allocation of the cost of tangible assets used within the Multiomics segment over their estimated useful lives. This non-cash expense reflects the wear and tear or obsolescence of equipment and infrastructure necessary for genomic and multiomics operations. Tracking this helps investors understand the capital intensity and asset replacement requirements of the segment.